The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. The key benefits of attending the […]

Panelists members include Kevin Outterson, Executive Director of CARB-X, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel. This panel will discuss the use of public-private partnerships as models […]